Help Protect Bioidentical Hormones!

Compounded bioidentical hormones are again in jeopardy of becoming inaccessible. In 2007, American women successfully blocked the FDA proposed ban on compounded estriol, with an overwhelming number of communications to Congress. Now we need your help to achieve this level of action again!

The FDA recently tasked and funded the National Academies of Science, Engineering, and Medicine (NASEM) to evaluate the “clinical utility” of compounded BHRT. NASEM has conducted several public meetings to date on compounded BHRT. The Committee designated experts to present to the NASEM panel.

However, many hours of testimony before the Committee were assigned to presenters who either oppose compounding and bioidentical hormone therapy entirely, or who represented uncommon (and therefore suspect) administration methods of compounded bioidentical hormone therapy.

Daved Rosensweet, M.D., is a BHRT expert and advocate. During one of the meetings, he was allowed to present— for just five minutes. Even in such a short time, Dr. Rosensweet was able to offer compelling evidence for the value and uses of compounded BHRT.

Dr. Rosensweet’s opinion is that the NASEM Committee members lack a fundamental understanding of how compounded BHRT is properly used to treat menopause. Lack of knowledge and experience leaves Committee members vulnerable to the torrent of misinformation and bias that they have received.

We must get Dr. Rosensweet more time to present to the NASEM Committee. Approximately 2.5 million women benefit from compounded BHRT annually, accounting for one half of all women who are being treated with hormones in menopause. We must stop the FDA from plowing forward unchecked, and restricting or even eliminating our access to compounded bioidentical hormones.

Recipients

Your Senators
Your Representative
National Academies of Sciences, Engineering, and Medicine

Contact

*Required fields

* Title:

* First Name:

* Last Name:

* Your Email:

* Address 1:

Address 2:

* City:

* State / Province:

* ZIP / Postal Code:

Country:

* Phone Number:

Yes, I would like to receive periodic updates and communications from Alliance for Natural Health USA.

Remember me. What's this?

Message

Please let Dr. Rosensweet present on bioidentical hormones

Dear [Decision Maker],

* Personalize your message

I am very troubled by the bias against compounded hormones that is apparent at the FDA.  As the Committee at the National Academies of Science, Engineering, and Medicine (NASEM) has deliberated the clinical utility of compounded bioidentical hormones, far more presentation time has been given to those who have a negative view of compounded bioidentical hormones, than to professionals who presented evidence in favor of their use.

Please let Daved Rosensweet, M.D. present to the NASEM Committee in person, with sufficient time to explain the many reasons why women and physicians are choosing compounded bioidentical hormone replacement therapy (cBHRT).

Given the apparent lack of expertise on the NASEM committee regarding these hormones, and of the treatment of menopause generally, it is imperative to give qualified experts who use, understand and support compounded bioidentical hormone therapy a fair chance to present their case.  So far, the meetings have been heavily biased against responsible use of cBHRT.

Over the course of three meetings and more than a dozen hours of presentations, the Committee has heard mostly from those who share the FDA's negative and highly critical position of cBHRT.  At this point, I believe that the Committee does not have an accurate understanding of the clinical use of cBHRT to treat menopause-- a shortcoming that must be addressed if the Committee is to reach a balanced, unbiased conclusion.

To help achieve that goal, I am asking that the FDA and the NASEM committee give Dr. Rosensweet (who was allowed a mere five minutes to present at the second meeting) sufficient time to educate the Committee about both the safety and the many benefits of compounded bioidentical hormones.

Dr. Rosensweet can educate committee members about a number of critical issues that are extremely relevant to the Committee's mission--including what women experience during menopause, and what constitutes true Standard of Care with cBHRT menopause medicine.

The FDA and NASEM owe it to the millions of men and women who rely on these compounded hormones to stay healthy, to give a full hearing to Dr. Rosensweet, an expert on bioidentical hormone therapy.  Please give him the chance to fully present his case, on behalf of the untold millions of citizens who will be greatly damaged if they are denied access to this valuable therapy.

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]